A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.

A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.

Item
http://www.wikidata.org/entity/Q34513982
B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B.Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.Tuberculosis vaccine development: Shifting focus amid increasing development challenges.Strategies to improve BCG vaccine efficacy.Modulation of Macrophage Responses by CMX, a Fusion Protein Composed of Ag85c, MPT51, and HspX from Mycobacterium tuberculosis.The mc2-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guérin but with similar lung inflammatory effects.The Role of Neutrophils in the Induction of Specific Th1 and Th17 during Vaccination against Tuberculosis.Identification of specific antibodies against the Ag85C-MPT51-HspX fusion protein (CMX) for serological screening of tuberculosis in endemic area.Commentary: The Role of Neutrophils in the Induction of Specific Th1 and Th17 during Vaccination against Tuberculosis.Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis.CHO expressed recombinant human lactoferrin as an adjuvant for BCG.Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of three protective mTB antigens, induces a potent Th1 immune response and protects mice against Mycobacterium tuberculosis infection.Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes.
P2860

A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.

Item
http://www.wikidata.org/entity/Q34513982
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A new recombinant BCG vaccine ...... efficacy against tuberculosis.
@ast
A new recombinant BCG vaccine ...... efficacy against tuberculosis.
@en
A new recombinant BCG vaccine ...... efficacy against tuberculosis.
@nl
type
label
A new recombinant BCG vaccine ...... efficacy against tuberculosis.
@ast
A new recombinant BCG vaccine ...... efficacy against tuberculosis.
@en
A new recombinant BCG vaccine ...... efficacy against tuberculosis.
@nl
prefLabel
A new recombinant BCG vaccine ...... efficacy against tuberculosis.
@ast
A new recombinant BCG vaccine ...... efficacy against tuberculosis.
@en
A new recombinant BCG vaccine ...... efficacy against tuberculosis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
A new recombinant BCG vaccine ...... efficacy against tuberculosis.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0112848
P407
P433
P478
P50
P577
P5875
P698
P921
P932